摘要
目的:探讨贝那普利和氯沙坦防治环孢素A(CsA)慢性肾毒性的疗效及作用机制。方法:50只SD大鼠随机分为对照组、模型组、贝那普利组、氯沙坦组、联合用药组,每组10只。低盐饲料饲养,以CsA15mg/(kg.d)皮下注射造模,贝那普利组、氯沙坦组、联合用药组分别以单用贝那普利、氯沙坦及两者联用灌胃治疗,对照组和模型组以同体积生理盐水灌胃。于第4周末处死动物,取肾脏作肾组织血管紧张素Ⅱ(AngⅡ)含量测定,Masson染色检测肾脏纤维化,免疫组织化学方法检测生长转化因子-β1(TGF-β1)和胶原Ⅲ(ColⅢ)的表达情况。结果:与对照组相比,模型组的肾组织AngⅡ含量、间质纤维化程度、TGF-β1、ColⅢ明显升高;单药治疗组间质纤维化程度、TGF-β1、ColⅢ较模型组均有所下降,联合用药组低于单药治疗组,差异均有统计学意义(P<0.05)。结论:贝那普利和氯沙坦可能是通过下调TGF-β1,抑制ColⅢ表达,从而延缓CsA大鼠肾间质纤维化进展。两者联合应用,疗效更显著。
Aim : To investigate the effect of benopril and losartan on CsA chronic nephrotoxicity. Methods:Fifty rats were allocated into control group, model group, benopril group, losartan group and benopril and losartan combination group randomly. With lower-salt diet, model rat was established by CsA ( 15 rag/( kg · d) ) , meanwhile, normal saline,benopril, losartan,or combination of benopril and losartan was given to rats in these groups. At the end of 4 weeks, kidneys were harvested. Ang Ⅱ was determined by immunoradiometry. Masson staining was performed, as well as TGF-β1 and Col m were determined by immunohistochemistry. Results:The degree of fibrosis, Ang Ⅱ,TGF-β1, and Col m in model group were significantly higher than control group. The degree of fibrosis,TGF-β1, and Col m in benopril group or losartan group decreased compared with model group. The parameters in the combination group were lower than those in benopril group or losartan group(P 〈0.05). Conclusion:Combination of benopril and losartan attenuate fibrosis in interstitial by down-regulating expression of TGF-β1 and Colin. The effect of combination of benopril and losartan is better than that of benopril or losartan.
出处
《郑州大学学报(医学版)》
CAS
北大核心
2007年第6期1055-1057,共3页
Journal of Zhengzhou University(Medical Sciences)
基金
河南省科技攻关基金资助项目0324410084
河南省杰出青年基金资助项目74100510006